Nu Skin Enterprises
Nu Skin Enterprises
NUS
NYSE
8.93
USD
29.99%
About
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand.
It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa.
The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 619.3K |
| Three Month Average Volume | 16.3M |
| High Low | |
| Fifty-Two Week High | 24.3999 USD |
| Fifty-Two Week Low | 8.8 USD |
| Fifty-Two Week High Date | 01 Sep 2023 |
| Fifty-Two Week Low Date | 13 Aug 2024 |
| Price and Volume | |
| Current Price | 8.93 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -22.17% |
| Thirteen Week Relative Price Change | -37.50% |
| Twenty-Six Week Relative Price Change | -35.75% |
| Fifty-Two Week Relative Price Change | -70.17% |
| Year-to-Date Relative Price Change | -61.17% |
| Price Change | |
| One Day Price Change | -3.88% |
| Thirteen Week Price Change | -33.11% |
| Twenty-Six Week Price Change | -29.35% |
| Five Day Price Change | -10.70% |
| Fifty-Two Week Price Change | -62.62% |
| Year-to-Date Price Change | -54.02% |
| Month-to-Date Price Change | -20.41% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 16.60541 USD |
| Book Value Per Share (Most Recent Quarter) | 13.80612 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 9.81598 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 10.0164 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 2.23305 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 39.4932 USD |
| Revenue Per Share (Trailing Twelve Months) | 36.6744 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 1.56 USD |
| Dividend Per Share (Trailing Twelve Months) | 0.9 USD |
| Dividend Per Share (5 Year) | 1.52 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 0.17238 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -2.99196 USD |
| Normalized (Last Fiscal Year) | 0.43038 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 0.1729 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -2.99196 USD |
| Including Extraordinary Items (Last Fiscal Year) | 0.17238 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -2.99196 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 5.45679 USD |
| Cash Per Share (Most Recent Quarter) | 4.68654 USD |
| Cash Flow Per Share (Last Fiscal Year) | 1.66426 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -1.50469 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 1.23935 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 2 |
| Cash Flow Revenue (Trailing Twelve Months) | 3 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -8.44% |
| Pretax Margin (Last Fiscal Year) | 1.35% |
| Pretax Margin (5 Year) | 7.23% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 68.93% |
| Gross Margin (Trailing Twelve Months) | 67.57% |
| Gross Margin (5 Year) | 73.45% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 2.45% |
| Operating Margin (Trailing Twelve Months) | -6.89% |
| Operating Margin (5 Year) | 7.72% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 0.44% |
| Net Profit Margin (Trailing Twelve Months) | -8.05% |
| Net Profit Margin (5 Year) | 5.26% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 3.31% |
| Tangible Book Value (5 Year) | -0.38% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -12.23% |
| Revenue Growth (3 Year) | -5.97% |
| Revenue Change (Trailing Twelve Months) | -9.70% |
| Revenue Per Share Growth | -3.60% |
| Revenue Growth (5 Year) | -8.64% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -3.63% |
| Total Debt (5 Year) | 3.70% |
| Dividends | |
| Dividend Growth (3 Year) | 1.32% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -543.94% |
| EPS Change (Trailing Twelve Months) | -312.15% |
| EPS Growth (3 Year) | -39.68% |
| EPS Growth (5 Year) | -63.78% |
| EBITDA | |
| EBITDA (5 Year) | -18.43% |
| EBITDA (5 Year Interim) | -22.21% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -37.43% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 7 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 225.4M |
| Net Debt (Last Fiscal Year) | 246.1M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | 21 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 120 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 8 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | 3.65% |
| Dividend Yield | 2.69% |
| Current Dividend Yield | 10.08% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 59 |
| Long Term Debt to Equity (Most Recent Quarter) | 62 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 903.11% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -17,473,000 |
| Free Cash Flow (Trailing Twelve Months) | 62.3M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 3 |
| Net Interest Coverage (Trailing Twelve Months) | 3 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 63 |
| Total Debt to Equity (Most Recent Quarter) | 67 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 0.47% |
| Return on Assets (Trailing Twelve Months) | -8.53% |
| Return on Assets (5 Year) | 6.80% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 1.00% |
| Return on Equity (Trailing Twelve Months) | -18.77% |
| Return on Equity (5 Year) | 14.28% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 0.58% |
| Return on Investment (Trailing Twelve Months) | -10.89% |
| Return on Investment (5 Year) | 8.90% |